Pharma & Biotech

Aclaris Therapeutics enters a pivotal week as the market braces for the company's third-quarter 2025 financial results, scheduled for release...

A pivotal moment approaches for Germany's biotechnology landscape as shareholders of CureVac prepare to vote on November 25 regarding a...

The upcoming quarterly report from biotechnology firm Iovance represents a pivotal moment for the company's stock trajectory. On Thursday, November...

Viking Therapeutics is experiencing significant positive momentum this October, driven by substantial progress in its obesity treatment candidate VK2735. The...

After an extended period of decline, BioNTech's stock is finally demonstrating positive momentum. The vaccine pioneer recorded gains exceeding 6...

Kodiak Sciences Inc. witnessed a dramatic trading session as its stock soared more than 11% to reach $21.05. The biotechnology...

Thermo Fisher Scientific delivered a powerful third-quarter 2025 performance that exceeded market expectations, creating an intriguing investment narrative as the...

This week represents a critical juncture for Teva Pharmaceutical, with two significant events poised to influence the company's stock trajectory....

Eli Lilly is currently redefining pharmaceutical success through its revolutionary weight-loss medications, propelling the company into unprecedented territory. The pharmaceutical...

Olema Pharmaceuticals has scheduled a critical presentation for December, where the biotechnology firm will unveil progress from its OPERA-02 Phase...